Building upon the standard of care in adjuvant therapy of high-risk melanoma.
Kirkwood
John M
JM
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant / Q000592:standards; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D015474:Isotretinoin / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D012307:Risk Factors; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D015474:Isotretinoin